VeriTeQ is a developer and marketer of innovative RFID technologies for implantable medical device identification and radiation dosimeters for use in cancer treatment. Our unique technology is used as a direct mark by medical device companies to identify implantable medical devices, in vivo, on demand, at the point of use, from outside the body. This technology is being used to help medical device manufacturers comply with the FDA’s Unique Device Identification (UDI) legislation. Specific examples include manufacturers of breast implants, vascular ports, pacemakers, as well as hip/knee/shoulder and spine replacements. VeriTeQ’s radiation dosimeters (both wearable and implantable) help radiation oncologists, therapists and physicists know the exact dosage of radiation penetrating a patient at the skin level and at the site of a tumor or tumor area. These medical devices provide cancer specialists with an excellent tool to help ensure patient safety and improve the overall quality of care.
Closing share price